4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-19-046347
Director sold 6,290 shares at an average $5.92 ($37,258)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bernard Gordon R Director | 2019-08-01 | Sale | −800 | $5.96 | $4,768 | 47,430 | D |
| Bernard Gordon R Director | 2019-08-02 | Sale | −400 | $6.07 | $2,428 | 47,030 | D |
| Bernard Gordon R Director | 2019-08-05 | Sale | −1,500 | $6.08 | $9,120 | 45,530 | D |
| Bernard Gordon R Director | 2019-08-07 | Sale | −700 | $5.98 | $4,186 | 44,830 | D |
| Bernard Gordon R Director | 2019-08-08 | Sale | −502 | $6.01 | $3,017 | 44,328 | D |
| Bernard Gordon R Director | 2019-08-09 | Sale | −188 | $5.79 | $1,089 | 44,140 | D |
| Bernard Gordon R Director | 2019-08-12 | Sale | −900 | $5.75 | $5,175 | 43,240 | D |
| Bernard Gordon R Director | 2019-08-13 | Sale | −1,300 | $5.75 | $7,475 | 41,940 | D |
| Open-market sales · 6,290 sh · avg $5.92 · $37,258 | |||||||
Loading xslF345X03/doc4.xml…